http://www.yso.fi/onto/yso/p16161 dexmedetomidine
dexmedetomidine
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha2-adrenoceptor antagonist MK-467 in dogs
Population pharmacokinetics in support of analgesics and anaesthetics studies in special populations
Dexmedetomidine and MK-467, a peripherally acting α2-adrenoceptor antagonist, in dogs
Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anesthesia
Patient-controlled sedation for endoscopic retrograde cholangiopancreatography
Sedative, analgesic, and cardiovascular effects of levomedetomidine alone and in combination with dexmedetomidine in dogs
Effects of exercise-induced stress and dexamethasone on plasma hormone and glucose concentrations and sedation in dogs treated with dexmedetomidine
α2-adrenoceptor-mediated vascular responses induced by dexmedetomidine
Human pharmacology of medetomidine, a selective alpha2-adrenoceptor agonist
Relation between body temperature and dexmedetomidine-induced minimum alveolar concentration and respiratory changes in isoflurane-anesthetized miniature swine
The effects of anesthetic induced loss of consciousness on quantitative electroen cephalogram, and bispectral and spectral entropy indices : studies on healthy male
24-hour Holter-monitoring in the perianaesthetic period in dogs premedicated with dexmedetomidine
Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration
Observations on the pharmakokinetics and pharmacodynamics of dexmedetomidine : clinical studies on healthy volunteers and intensive care patients
Observations on the pharmacokinetics and pharmacodynamics of dexmedetomidine : clinical studies on healthy volunteers and intensive care patients
Use of the alpha-2-adrenoceptor agonists medetomidine and dexmedetomidine in the sedation and analgesia of domestic cats
Correlation between serum concentrations following continuous intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects
The alpha[sub]2C-adrenoceptor as a neuropsychiatric drug target : PET studies in human subjects
Changes in the minimum alveolar concentration of isoflurane and some cardiopulmonary measurements during three continuous infusion rates of dexmedetomidine in dogs
Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs
